Cambrex to Present at UBS Global Healthcare Conference
Get Alerts CBM Hot Sheet
Join SI Premium – FREE
EAST RUTHERFORD, N.J., May 16, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM) (“Cambrex”) is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the UBS Global Healthcare Conference on May 23, 2016 at 9:30 a.m. EDT in New York City.
The live audio webcast and slide presentation can be accessed from the Cambrex website at www.cambrex.com in the Investors section under “Webcasts & Presentations”, and a replay will be available for 90 days after the live event concludes.
About Cambrex Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
Contact: Stephanie LaFiura Investor Relations Associate Phone: 201.804.3037 Email: [email protected]Source: Cambrex Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mobvista Achieves $1.05B in 2023 Revenue, Sees Significant Profit Increase
- Groq® Is Still Faster
- Todd Stager, Esteemed SEO for Lawyers Expert, Embarks on a New Journey with His Own SEO Firm
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!